As the global economy recovers in 2021 and the supply of the industrial chain improves, the Tumor Genomics market will undergo major changes. According to the latest research, the market size of the Tumor Genomics industry in 2021 will increase by USD million compared to 2020, with a growth rate of %.

The global Tumor Genomics industry report provides top-notch qualitative and quantitative information including: Market size (2017-2021 value and 2022 forecast). The report also contains descriptions of key players, including key financial indicators and market competitive pressure analysis.

The report also assesses key opportunities in the market and outlines the factors that are and will drive the growth of the industry. Taking into account previous growth patterns, growth drivers, and current and future trends, we also forecast the overall growth of the global Tumor Genomics market during the next few years. The global Tumor Genomics market size will reach USD million in 2028, growing at a CAGR of % during the analysis period.

Highlights-Regions

The Tumor Genomics market can be split based on product types, major applications, and important regions as follows:

North America
Europe
Asia Pacific
Latin America

Player list
Abbott Laboratories
Agilent Technologies, Inc
Bio-Rad Laboratories, Inc.
Danaher Corporation
F. Hoffmann-La Roche Ltd
Fluidigm Corporation
General Electric Company
Illumina, Inc.
Merck KGaA
Myriad Genetics, Inc.
Pacific Biosciences of California, Inc.
PerkinElmer
QIAGEN
Siemens Healthineers AG
Thermo Fisher Scientific Inc.

Types list
Assays and Kits
Instrument

Application list
Diagnostics and Monitoring
Drug Discovery and Development
Biomarker Discovery